In October 2019, the FDA approved emtricitabine/tenofovir alafenamide (FTC/TAF) as a second option for HIV PrEP in at-risk adults and adolescents but excluded cisgender women from the approval because of a lack of efficacy data. The FTC/TAF decision underscored existing concerns over leaving women out of clinical research. “There are sex differences in immune responses, drug metabolism and disease states. Some differences are mediated by hormonal differences and others by other biological factors,” said Infectious Disease News Editorial Board Member Elizabeth Connick, MD, professor of medicine and chief of the division of infectious diseases at the University of Arizona College of Medicine.

The gift from breast cancer survivor and longtime UArizona supporter Ginny Clements establishes an endowment for the new institute, along with endowed positions and renovated lab space.

As the Mel and Enid Zuckerman College of Public Health celebrates its 20th anniversary, look back at the important events and people that contributed to its success.

By considering the general public a key audience, researchers can generate more enthusiasm, trust and funding for science.

Can Some Non-Hodgkin Lymphoma Patients Skip Radiation? The new study, published in the Journal of Clinical Oncology, enrolled 132 eligible patients with stage I and II diffuse large B-cell lymphoma (DLBCL). The study was led by Dr. Daniel Persky, a professor of medicine at the University of Arizona College of Medicine and associate director for clinical investigations at the University of Arizona Cancer Center in Tucson.

Quit smoking. “Cigarette smoking is probably public enemy number one,” says Joseph Alpert, MD, a cardiologist as the University of Arizona Sarver Heart Center. “People who smoke a pack of cigarettes a day are twice as likely to get a heart attack over non-smokers.”

A breast cancer survivor and longtime supporter of the University of Arizona has given $8.5 million to the University of Arizona Cancer Center to strengthen the center's breast cancer patient care and research programs.

The Tohono O'odham Nation has committed $1 million to the University of Arizona to help researchers fight COVID-19. UA researchers have been involved in understanding the coronavirus and testing people across the state since the pandemic’s arrival in the United States in the spring. An antibody test developed by immunologists in the College of Medicine-Tucson has been deployed throughout Arizona in partnership with Gov. Doug Ducey, according to the UA.

Dr. Cara Christ, director of the Arizona Department of Health Services, said Arizona is at a "pivotal" moment for COVID-19. Daily case reports are about the same as seen in late May and early June, four weeks before the peak of the outbreak. Given that Arizona is at that level now, it's possible rapid infection could take off, said Joe Gerald, an associate professor at University of Arizona's Mel and Enid Zuckerman College of Public Health. "It's almost as if we have a loaded gun in our hand and if we're not careful, it can go off and hurt someone," he said of the case trends.